Keyphrases
Systemic Lupus Erythematosus
100%
Psoriatic Arthritis
93%
Rheumatoid Arthritis
80%
Vaccination
40%
Healthy Controls
39%
Disease Activity
36%
Autoimmune Inflammatory Rheumatic Disease
33%
Rheumatoid Arthritis Patients
31%
Arthritis Patients
31%
Antiphospholipid Syndrome
29%
Immunogenicity
29%
Fibromyalgia
27%
Humoral Response
26%
Rituximab
24%
Infliximab
19%
Systemic Lupus Erythematosus Patient
17%
Ankylosing Spondylitis
16%
Methotrexate
16%
Enthesitis
16%
Vaccination Safety
16%
Influenza
16%
Tumor Necrosis Factor-α Blocker
15%
SLE Disease Activity Index (SLEDAI)
14%
Primary Sjögren's Syndrome
14%
Influenza Vaccination
14%
Adalimumab
14%
Lupus
13%
Rheumatic Diseases
12%
Disease Activity Score
12%
Autoimmune Disease
11%
Patients with Fibromyalgia
11%
Magnetic Resonance Imaging Study
10%
Disease-modifying Antirheumatic Drugs (DMARDs)
10%
Ultrasound
10%
Geometric Mean Titer
10%
Somatostatin
10%
Israeli
10%
BNT162b2 Vaccine
9%
Pneumococcal Vaccination
9%
Systemic Lupus Erythematous
9%
Endothelial Progenitor Cells
9%
Quinacrine
9%
Impaired Learning
9%
Impaired Memory
9%
Learnability
9%
Cat Scratch Disease
9%
Somatostatin Analogs
9%
Systemic Sclerosis
9%
Intravenous Immunoglobulin (IVIg)
9%
IgA Rheumatoid Factor
9%
Immunology and Microbiology
Psoriatic Arthritis
73%
Inflammatory Arthritis
72%
Vaccination Policy
63%
Systemic Lupus Erythematosus
47%
Influenza
36%
Immunogenicity
28%
Rheumatic Disease
28%
Vaccine Efficacy
26%
Humoral Immunity
25%
Tumor Necrosis Factor
22%
Rituximab
21%
Prevalence
21%
Monospecific Antibody
18%
Infliximab
17%
Ankylosing Spondylitis
14%
Influenza A Virus (H1N1)
13%
Methotrexate
12%
COVID-19
11%
Lupus Erythematosus
11%
Influenza Vaccine
10%
Biological Product
10%
Titer
9%
Autoantibodies
9%
Population
9%
Sputum
9%
Sjögren's Syndrome
9%
Systemic Scleroderma
9%
Secukinumab
9%
TNF Inhibitor
9%
Endothelial Progenitor Cell
9%
Disease-Modifying Antirheumatic Drug
9%
Rheumatoid Factor
8%
Synovitis
8%
Tenosynovitis
8%
Arthritis
8%
ELISA
8%
Arthropathy
7%
Adalimumab
7%
C-Reactive Protein
7%
Antinuclear Antibody
7%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Immunoglobulin M
6%
Glucocorticoid
6%
Monocyte
6%
Osteoarthritis
5%
Immunoglobulin A
5%
Adoptive Immunity
5%
Influenza Virus
5%
Tumor Necrosis Factor Alpha
5%
Cardiolipin Antibody
5%
Medicine and Dentistry
Systemic Lupus Erythematosus
65%
Psoriatic Arthritis
36%
Rheumatoid Arthritis
31%
Rheumatic Disease
28%
Antiphospholipid Syndrome
25%
Disease Activity
22%
Rituximab
18%
Prevalence
18%
Ankylosing Spondylitis
16%
Influenza Vaccination
14%
Methotrexate
12%
Influenza A Virus (H1N1)
11%
Rheumatology
11%
Autoantibodies
11%
Magnetic Resonance Imaging
11%
Disease
10%
Humoral Immunity
10%
Fibromyalgia
9%
Symptom
9%
Cat-Scratch Disease
9%
Systemic Scleroderma
9%
Silo-Filler's Disease
9%
Infliximab
9%
Spondyloarthropathy
9%
Antiphospholipid Antibody
9%
Arthropathy
8%
B Cell
7%
Leukocyte
7%
Backache
7%
Induced Sputum
6%
Antinuclear Antibody
6%
SLEDAI
6%
Biological Product
6%
Endocarditis
6%
Polymyalgia Rheumatica
5%
Sacroiliitis
5%
Lung Diffusion Capacity
5%
Inflammatory Bowel Disease
5%
Rey Auditory Verbal Learning Test
5%
Biological Marker
5%
Morning Stiffness
5%
Tumor Necrosis Factor
5%
